chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Migraine; Vertigo; Pain in arm; Pain in arm chest; Pain in arm chest breast; Loss of appetite; Very tired; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the left arm on 22Aug2021 at 11:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified antibiotics (MANUFACTURER UNKNOWN), taken for an unspecified indication from an unknown date and unknown if ongoing. On 22Aug2021 at 14:30, the patient experienced migraine, vertigo, pain in arm, chest and breast, loss of appetite and very tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, vertigo, pain in arm, chest and breast, loss of appetite and very tired was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
High Fever 101.8 that could not be controlled with standard over the counter medications.  Severe body aches in muscles and joints,  dizziness to the point of tunnel vision, difficulty breathing, uncontrollable diarrhea, dehydration, headache symptoms similar to a migraine. .
Information has been received from a health professional concerning a 9 year old male who on 15-JUN-2007 was vaccinated SC on left deltoid with a first dose of Zostavax (Oka/Merck) (Lot # 656607/0163U).  It was reported that the patient was supposed to received second dose of Varivax (Oka/Merck) (MSD).  It was reported that it was human error not a product confusion.  Additional information stated that the patient had no reaction.  No further information is expected.  The patient's siblings had similar experiences after therapy with Zostavax (MSD) WAES # 0707USA01865 and WAES # 0706USA02773.
Cellulitis reaction on left thigh @ site of injection Treatment -Keflex  25015 11/2 tsp BID
reported rash on most of body;no temp;very itchy stated by mom;pt seen by MD 30APR;
This spontaneous report as received from a licensed practical nurse (L.P.N.) refers to a currently 14 years old female patient with no pertinent medical history and no drug reactions/allergies. On an unknown date, when the patient was 11 years old, she was vaccinated with a dose of GARDASIL, intramuscularly, dose and lot # unspecified. (Nurse confirmed this was documented in the patient's chart, but the patient's mother denies the child received the GARDASIL). There were no concomitant medications. On an unknown date, 9 months after vaccination the patient experienced seizures resulting in a two weeks hospital admission to an unspecified hospital. Nurse reported that six months after being discharged from the hospital, patient again experienced seizures (date unknown), resulting in a two day admission to an unspecified hospital. Patient was discharged from the hospital on an unspecified date. The nurse reported that seizures had affected activities of patient's daily living and determined seizures to be disabling. Nurse was unaware of patient's treatment. The outcome of seizures was reported as not recovered/not resolved. The relatedness between GARDASIL and adverse event was unknown. Upon internal review, seizures were considered to be medically significant. Additional information has been requested.
Post vax, pt started coughing, then started vomiting. Pt turned blue on the way to the car. Pt was retracting, wheezing and having a very difficult time breathing. Pt brought back to office and given treatment and sent to ED and given Solu-Medrol and Benadryl. Pt needed to be admitted to the hospital for treatment. Dx: allergic reaction.
My right arm has a red rash that is warm, slightly raised (swollen) and slightly itchy.
This spontaneous report was received from a registered nurse refers to an 11 month 365 days old patient of unknown gender. Patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On 11-DEC-2002 the patient was vaccinated with MMR II (strength, dose, frequency, route, lot #, expiry date unspecified). No concomitant medications were reported. No adverse effect was reported. Additional information has been requested.
Pt c/o of lightheadedness, diaphoretic, pallor 15 minutes after vaccine administration. Pt placed flat on ground with pillow and feet elevated. apple juice, water and cold compresses provided. 15 minutes later pt still symptomatic, transferred to  Ste 285.. Bp 128/75(88), pulse 83, o2 99%, RR 20.
Bright yellow liquid pour out of right nostril for about 8 seconds. I did not or do not have a stuffy or runny nose.   Swelling in armpit area in "covid arm" armpit is swollen and sensitive to touch. Slight movements or any pressure is very painful.
Arm was sore for 2 days after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore for 2 days after the first dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore for 2 days after the first dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 24-Feb-2021, PAIN IN EXTREMITY (Arm was sore for 2 days after the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medications includes heart medications and diabetic medications   This case was linked to US-MODERNATX, INC.-MOD-2021-065257 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-065257:Cross-linked with second dose
Vaccine under constituted with 1.3 mLs diluent ie 5mcg/1.3mLs vaccine administered
Vaccine expired on 08 Nov 2021, moved to refrigerator on 11 Nov 2021 and 25 Nov 2021, Administered on 15 DEC 2021; Vaccine expired on 08-Nov-2021 and was administered on 15-Dec-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08-Nov-2021 and was administered on 15-Dec-2021) and PRODUCT STORAGE ERROR (Vaccine expired on 08 Nov 2021, moved to refrigerator on 11 Nov 2021 and 25 Nov 2021, Administered on 15 DEC 2021) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08-Nov-2021 and was administered on 15-Dec-2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 08 Nov 2021, moved to refrigerator on 11 Nov 2021 and 25 Nov 2021, Administered on 15 DEC 2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08-Nov-2021 and was administered on 15-Dec-2021) and PRODUCT STORAGE ERROR (Vaccine expired on 08 Nov 2021, moved to refrigerator on 11 Nov 2021 and 25 Nov 2021, Administered on 15 DEC 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Date moved to refrigeration reported as 11-Nov-2021 and 25-Nov-2021.  Treatment details was not reported by the reporter.   This case was linked to MOD-2022-570635, MOD-2022-570637, MOD-2022-570643, MOD-2022-578385 (Patient Link).
Tested positive for COVID-19 after 1st dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19 after 1st dose of the vaccine) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19 after 1st dose of the vaccine). At the time of the report, COVID-19 (Tested positive for COVID-19 after 1st dose of the vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Coronavirus test: (Positive) Tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
extremely fatigued; body aches; This is a spontaneous report from a contactable consumer or other non hcp. A 37-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration, administered in Arm Right on 26Feb2021 (at the age of 37-years-old) as dose 1, single for covid-19 immunisation.  Medical history included multiple sclerosis, allergic to Kiwi and Tomatoes. Concomitant medication included vitamin d nos. On 26Feb2021 at 14:30, the patient experienced extremely fatigued and body aches. Treatment was not received for the events. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. This case was reported as non-serious as it did not meet any of the seriousness criteria. Prior to vaccination, the patient was not diagnosed with COVID. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events were recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
HEART RACING/RAPID HEART RATE; SHORTNESS OF BREATH; ANXIOUS FOR MAY BE GETTING A BLOOD CLOT; UNUSUAL ABDOMINAL PAIN; FEELING LIGHTHEADED; TINGLING SENSATION OF ARMS & LEGS; FLU-LIKE SYMPTOMS (CHILLS, FEELING FEVERISH, FATIGUE); This spontaneous report received from a patient concerned a 22 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-smoker, and non-alcohol user, and other pre-existing medical conditions included: The patient has no known allergies and does not abuse or illicit drug usage. The patient does not consume any birth control medication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855835, and batch number: 1855835 expiry: 27-APR-2022) dose was not reported, administered on 27-DEC-2021 for prophylactic vaccination. No concomitant medications were reported.  On 27-DEC-2021, the patient experienced flu-like symptoms (chills, feeling feverish, fatigue). On 01-JAN-2022, the patient experienced heart racing/rapid heart rate, shortness of breath, anxious for may be getting a blood clot, unusual abdominal pain, feeling lightheaded, and tingling sensation of arms & legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu-like symptoms (chills, feeling feverish, fatigue) on 29-DEC-2021, and had not recovered from heart racing/rapid heart rate, shortness of breath, anxious for may be getting a blood clot, unusual abdominal pain, tingling sensation of arms & legs, and feeling lightheaded. This report was non-serious.
Face started to tingle then went numb roughly 45-55 minutes after receiving.; Face started to tingle then went numb roughly 45-55 minutes after receiving.; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient received bnt162b2 (lot number: EL0140, Pfizer- BioNTech), intramuscularly at arm left, first dose on 23Dec2020 07:45, at single dose, for COVID-19 immunization. Medical history included environmental allergies, iron deficiency anemia, endometriosis, allergies to penicillin, and allergies to preservatives in flu vaccine from an unknown date. The patient is not Pregnant at the time of vaccination. Concomitant medication included ibuprofen, colecalciferol (VITAMIN D), cyanocobalamin (VITAMIN B12), magnesium, all from an unspecified date, for unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Age at vaccination is 45 Years old. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced face started to tingle then went numb roughly 45-55 minutes after receiving (reported as from 23Dec2020, 08:30 AM). Not sure if that is an actual reaction but it occurred. The event was reported as non-serious. Therapeutic measures were taken as a result of face started to tingle then went numb roughly 45-55 minutes after receiving, treatment included BENADRYL orally taken. The outcome of the event was recovered in Dec2020.
Shortness of breath about 20 minutes after the shot,and continued until evening.  Little bit the next day. Did not seek help as I did not see this on the reaction list until late in the evening while I was searching to see if this was one of the side effects.
Patient complaining about injection site irritation after removing band-aid the day after vaccine. Skin looked raw and had pus forming.
ON 7/29/2002 PATIENT CAME INTO OFFICE WITH SPOTTING ON BOTH LEGS,AFTER GETTING VACCINES ON 7/23/2002. DIAGNOSES WAS ERYTHEMA MULTIFORME (695.1). BOLD APPEARING ON RIGHT THIGH, FAINT APPEARING ON RIGHT LOWER LEG AND ON THE LEFT THIGH. ALSO COMPLAINTS OF BEING SICK TO STOMACH 1 DAY AFTER SHOTS FOR 24 HOURS. STATE SUPPLIED VAC.
This spontaneous report as received from a healthcare professional refers to an unknown number of patients (age and genders were not reported). On unknown dates, the patients were vaccinated with MMR II, (Merck) PROQUAD and (Merck) VARIVAX (doses, routes of administration and lot numbers were not reported), that had been improperly stored. No adverse effect reported. Additional information has been requested.
Cough, shortness of breath, SPO2 decreased to 88-90% 24-36 hours after vaccine administration. Normal vital signs on 1/9/21 at time of urgent care visit
2 days after vaccination patient developed episodes of diarrhea 3-4 times a day.
Rapid heart rate, immediately; Body warmed up immediately; This spontaneous case was reported by a health care professional and describes the occurrence of HEART RATE INCREASED (Rapid heart rate, immediately) and FEELING HOT (Body warmed up immediately) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A021A) for COVID-19 vaccination.     Concomitant products included VITAMIN D NOS and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced HEART RATE INCREASED (Rapid heart rate, immediately) and FEELING HOT (Body warmed up immediately). At the time of the report, HEART RATE INCREASED (Rapid heart rate, immediately) and FEELING HOT (Body warmed up immediately) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication also includes Antihyperlipidemic and Eye drops
Zostavax vaccine was given via intramuscular route instead of via subcutaneous route.
expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information not provided.  Treatment information not provided.  Per Moderna CMC Lot analysis, regarding doses administered on 13Jul2021 from lot# 006B21A and 10Jul2021 from lot# 009C21A: Moderna cannot guarantee patients received full protection against the COVID-19 Virus.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: follow up received with No new information. The causality for Regulatory Authority was corrected from initial version from Possible to Not applicable.
Swollen Lips, throat, foot, sore throat, body aches, chills, head aches, Feeling that can not keep eyes open, pain on administration site, on/off body itching.
Pt said there was severe, persistent pain in her arm at the injection site that has interfered with her daily activity.
that morning awoke with extreme chills, sweating.  Felt like there was a fire inside my core. Could not sleep all night. Put on a sweatshirt. symptoms subsided next day. had headaches, felt fatigued.
This spontaneous report as received from a nurse via a company representative refers to a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of VARIVAX (Merck) (subcutaneously, lot # reported as L044524, expiration date 09-NOV-2017; dose was not reported). On an unknown date, the patient experienced local reaction, swelling, redness and pain. He sought medical attention via speaking with the nurse. The outcome of the adverse events was reported as recovering. The relatedness between the adverse events and VARIVAX (Merck) was not provided. This is one of two reports received from the same reporter. One of the patients (unspecified) received an unspecified imaging testy (results were unavailable at the time of this report). Additional information has been requested.
After 4 hours after vaccine administration, patient felt chills and didn't feel right, then pt had dinner but he couldn't hold spoon, pt called pharmacy, advised him to take TYLENOL then will feel better. Then they called doctor, Dr advised to take BENADRYL. Friday pt felt a little bit better with something bother pt on throat with difficulty swallowing. Saturday pt started to feel tightness in chest then blood pressure 80/50 and pulse 220. Sunday pt felt the same but worse toward night. Early Monday pt went to Dr then MD sent him to hospital. Before going to hospital MD did couple tests -> MD said he has pericarditis condition then MD sent him to hospital. Pt stay at hospital for 3 days. Sodium level was low.
no adverse event; GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE; GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE), PRODUCT TEMPERATURE EXCURSION ISSUE (GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE) and NO ADVERSE EVENT (no adverse event) in a 14-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 048L21A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular use) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE) and PRODUCT TEMPERATURE EXCURSION ISSUE (GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE), PRODUCT TEMPERATURE EXCURSION ISSUE (GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular use), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE) and PRODUCT TEMPERATURE EXCURSION ISSUE (GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE).    Concomitant medication was not provided. Treatment information was not reported.
Headache, temperature, hot/cold, achy for 2-1/2 days
Dose administered after manufacturer date of expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after manufacturer date of expiry) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  One of the medical assistants or nurses gave a Moderna COVID-19 vaccination after its expiration date. The expiration date tool states it is 29 Apr 2022 and they administered it on 03 May 2022. Vial did not  undergo any temperature excursions.  No treatment medications were reported.
I was starting to feel like I was waking up with phlem and constant dry coughing and wheezing. It had been going on for a while. But I had not been taking my allergy medication as I should have. I just moved to new location, so I chalked it up to my allergies. I was prescribed a inhaler and so far it has been helpful.